Align Technology Wins Patent Infringement Case Against Angelalign in Unified Court

Key Facts

The Unified Patent Court ruled that Angelalign's aligner systems infringe on Align Technology's European patent. Business Wire reported that the legal proceedings, initiated by Align in August 2025, centered on its proprietary Power Ridge technology, claiming that Angelalign's Torque Ridges feature violated its medical device patents.

ALGN closed at $147.31 on October 16, 2026, with the stock trading between a session low of $146.14 and a high of $152.26. This legal victory serves to protect Align Technology's intellectual property and market position within the competitive medical device manufacturing sector.